Tigecycline combination for ventilator-associated pneumonia caused by extensive drug-resistant Acinetobacter baumannii

Journal of Thoracic Disease

Bing Sun²  Zhaohui Tong²  Xiao Tang²  Yali Zheng¹  Hangyong He²  Rui Wang² 

[1] Department of Respiratory and Critical Care Medicine, Peking University International Hospital, Beijing 102206, ChinaDepartment of Respiratory and Critical Care Medicine, Peking University International Hospital, Beijing 102206, ChinaDepartment of Respiratory and Critical Care Medicine, Peking University International Hospital, Beijing 102206, China;Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Key Laboratory of Respiratory and Pulmonary Circulation, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, ChinaDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Key Laboratory of Respiratory and Pulmonary Circulation, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, ChinaDepartment of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Key Laboratory of Respiratory and Pulmonary Circulation, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China

关键词: Tigecycline (TGC);    ventilator-associated pneumonia (VAP);    Acinetobacter baumannii (A. baumannii);    combination therapy;    outcome;   

DOI  :  10.21037/jtd.2016.10.29

学科分类：呼吸医学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown